Aling Shen

机构：Fujian University of Traditional Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Digestive Diseases, Ministry of Education, Jiangyin Traffic Planning Survey & Design Institute (China), Xiyuan Hospital, Center for Innovation, Tan Kah Kee Innovation Laboratory · ORCID：0000-0002-5081-3523

发表论文 140 篇 · 总被引 2233 次 · h-index 29

代表论文

• Baicalin alleviates angiotensin II‐induced cardiomyocyte apoptosis and autophagy and modulates the AMPK/mTOR pathway (2024 · Journal of Cellular and Molecular Medicine · 被引 32)
• Enhancing the therapeutic potential of isoliensinine for hypertension through PEG-PLGA nanoparticle delivery: A comprehensive in vivo and in vitro study (2024 · Biomedicine & Pharmacotherapy · 被引 17)
• Dehydrocorydaline attenuates myocardial ischemia-reperfusion injury via the FoXO signalling pathway: A multimodal study based on network pharmacology, molecular docking, and experimental study (2024 · Journal of Ethnopharmacology · 被引 14)
• Panax notoginseng saponin mitigates glycolysis to regulate macrophage polarization and sphingolipid metabolism via hypoxia-inducible factor-1 to alleviate atherosclerosis (2025 · Phytomedicine · 被引 7)
• Baicalin ameliorates angiotensin II-induced cardiac hypertrophy and mitogen-activated protein kinase signaling pathway activation: A target-based network pharmacology approach (2024 · European Journal of Pharmacology · 被引 7)
• Neferine attenuates hypertensive cardiomyocyte apoptosis and modulates key signaling pathways: An in vivo and in vitro study (2025 · European Journal of Pharmacology · 被引 5)